Dominick Nargi

Liposome encapsulation of curcumin and resveratrol in combination reduces prostate cancer incidence in PTEN knockout mice

Narayanan K. Narayanan, Dominick Nargi, Carla Randolph et al. · International Journal of Cancer · 2009 · 349 citations · Full text

Medicine, Oncology, Pharmacology +17

RNA interference–mediated cyclooxygenase-2 inhibition prevents prostate cancer cell growth and induces differentiation: modulation of neuronal protein synaptophysin, cyclin D1, and androgen receptor

Bhagavathi A. Narayanan, Narayanan K. Narayanan, Leland Davis et al. · Molecular Cancer Therapeutics · 2006 · 53 citations

Medicine, Molecular Biology, Oncology +17

Docosahexaenoic acid in combination with celecoxib modulates HSP70 and p53 proteins in prostate cancer cells

Narayanan K. Narayanan, Bhagavathi A. Narayanan, Maarten C. Bosland et al. · International Journal of Cancer · 2006 · 39 citations · Full text

Medicine, Oncology, Pharmacology +14

Exisulind in Combination with Celecoxib Modulates Epidermal Growth Factor Receptor, Cyclooxygenase-2, and Cyclin D1 against Prostate Carcinogenesis:<i>In vivo</i>Evidence

Bhagavathi A. Narayanan, Bandaru S. Reddy, Maarten C. Bosland et al. · Clinical Cancer Research · 2007 · 35 citations

Medicine, Oncology, Pharmacology +14

Inflammatory processes of prostate tissue microenvironment drive rat prostate carcinogenesis: Preventive effects of celecoxib

Narayanan K. Narayanan, Dominick Nargi, Lori Horton et al. · The Prostate · 2008 · 33 citations

Medicine, Immunology, Pathology +17